-
In a first, doctors injected the gene-editing tool CRISPR directly into cells in patients' eyes. The experiment helped these vision-impaired patients see shapes and colors again.
-
The unprecedented study involves using the gene-editing technique CRISPR to edit a gene while it's still inside a patient's body. In exclusive interviews, NPR talks with two of the first participants.
-
Dotty St. Amand, CEO of Lighthouse of Southwest Florida, which assists people with visual impairment, says that getting clients vaccinated is of great concern.
-
Florida State University has posted signs on campus and inside buildings asking students to wear masks and practice social distancing. But some students are having a difficult time accessing all of Florida State University's COVID-19 guidelines.
-
A deal finalized over the weekend will allow blind voters to fill out ballots secretly at home, putting an end to a broader legal tangle over Florida’s…
-
Software that can replace doctors for certain tasks has a big responsibility. The Food and Drug Administration is now figuring out how to determine when computer algorithms are safe and effective.
-
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising…
-
Supplements with the antioxidant lutein and omega-3 fatty acids didn't stop age-related macular degeneration, the leading cause of blindness in the United States, a new study suggests. But other antioxidants, including vitamins C and E, do seem to help.